| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_MAT2B_0000200 | Exon-Exon | chr5:162939008-162943717 | chr5:163512002-163516711 | 657 nt | 0.4353 |
| hsa_MAT2B_0000300 | Exon-Exon | chr5:162939008-162944680 | chr5:163512002-163517674 | 771 nt | 0.4371 |
| hsa_MAT2B_0000500 | Exon-Exon | chr5:162940561-162944680 | chr5:163513555-163517674 | 576 nt | 0.4427 |
| hsa_MAT2B_0000700 | Exon-Exon | chr5:162943524-162944680 | chr5:163516518-163517674 | 308 nt | 0.4643 |
| hsa_MAT2B_0000100 | Intergenic-Exon | chr5:162870680-162939202 | chr5:163443674-163512196 | 195 nt | 0.4205 |
| hsa_MAT2B_0000400 | Exon-Exon | chr5:162939008-162940675 | chr5:163512002-163513669 | 310 nt | 0.4290 |
| hsa_chr5_0318100 | Intergenic-Intergenic | chr5:162940193-162940556 | chr5:163513187-163513550 | 364 nt | 0.3516 |
| hsa_MAT2B_0000600 | Exon-Exon | chr5:162940561-162943717 | chr5:163513555-163516711 | 462 nt | 0.4416 |
| hsa_chr5_0318200 | Intergenic-Intergenic | chr5:162944587-162945359 | chr5:163517581-163518353 | 255 nt | 0.4667 |
| hsa_MAT2B_0000800 | Exon-Exon | chr5:162945480-162945662 | chr5:163518474-163518656 | 183 nt | 0.3497 |
A study in hepatocellular carcinoma demonstrated that the circMAT2B promotes cancer progression by enhancing glycolysis via the miR-338-3p/PKM2 axis [Huang et al. DOI:10.3390/cells11091381].